|
|
|
|
|
|
|
|
|
|
| Email |
register@iirusa.com
|
|
| Category |
Health: Pharmacy
|
|
| Category 2 |
Science: Biochemistry
|
|
|
|
|
|
| Contact |
Institute for International Research
708 Third Avenue - 4th Floor
New York, NY 10017
|
|
|
|
|
|
| Description |
"The ONLY preclincial forum on how to:
• Build capacity
• Enhance capability and
• Cut costs when outsourcing preclincial studies
Time, cost, quality and flexibility—key components to a
preclinical outsourcing relationship—are not easy to balance.
The volatility of shifting goals, study start dates and changes to
study designs, availability of study subjects and testing facilities
at the lab and budgetary decisions that may not be aligned with
an outsourcing strategy all contribute to the success or failure of
a project. Preclinical outsourcing is on the rise and with it, there
is an increased demand for capacity at outsourced facilities.
Our 2nd annual conference covers the critical elements to
streamline preclinical projects and help sponsors and providers
do a better job of working together to kill unsuccessful
compounds and promote promising candidates faster.
The Institute for International Research is delighted to
present the 2nd annual conference on Optimizing Preclinical
Outsourcing. IIR has over 15 years of experience organizing
pharmaceutical outsourcing conferences that deliver best
practices for tactical and strategic interactions between
pharmaceutical and biotech companies and their R & D
service providers.
IIR’s 2nd Annual Optimizing Preclinical Outsourcing has been designed to
balance the tactical and strategic needs of small, mid-sized and large
pharmaceutical and biotech companies, as well as companies providing
preclinical services to them. Our target audience includes professionals
with titles including:
• VP/Director
Preclincal
Development
• VP/Director
Toxicology
• Director of
Metabolism
• Director of DMPK
• Head of Outsourcing
• Head of Procurement
• Study Director
• Study Monitor
• Lead QA
• Test Site QA
• Project Manager
Target departments
include:
• Drug Safety
• Pre-Clinical R & D or
Non-Clinical
• Early Development
• Drug Disposition
• Drug Evaluation
• Drug Metabolism
• PK/PD
• Toxicology
• Pathology
• Bioanalytical
Development
• Scientific Affairs
• Laboratory Animal
Medicine
• Quality Assurance/
Quality Control
• Regulatory Affairs
• Outsourcing
• Contracts
• Legal
This conference will also be of interest to: Contractor Research Organizations,
Pharmaceutical Consultants, Technology Vendors and Academics in the
Pharmaceutical Sciences and to FDA personnel."
|
|
|
|
